CONFERENCE UPDATE: ILC 2022

Evaluation of the clinical and economic values of SOF/VEL in CHC patients

Glossary: CHC: Chronic hepatitis C; DAA: Direct-acting antiviral; HCC: Hematocellular cacinoma; HCV: Hepatitis C virus; RBV: Ribavirin; SOF/VEL: Sofosbuvir/velpatasvir; SVR: Sustained virologic responses

Get access to our exclusive articles.
Related Articles